| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.1M | -74.7% |
| R&D Expense | $17.9M | -5.9% |
| SG&A Expense | $13.9M | -5.6% |
| Operating Income | -$28.6M | -33.8% |
| Pre-tax Income | $7.0M | +123.9% |
| Net Income | $8.0M | +128.2% |
| EPS (Basic) | $1.57 | +125.9% |
| EPS (Diluted) | $1.57 | +125.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.6M | -49.7% |
| Current Assets | $27.4M | -47.8% |
| Total Assets | $34.2M | -39.6% |
| Current Liabilities | $8.7M | -75.0% |
| Long-term Debt | $4.0M | -75.0% |
| Total Liabilities | $16.2M | -70.7% |
| Stockholders' Equity | $18.0M | +1378.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.0M | +3.0% |
| Capital Expenditures | $29K | -95.9% |
| Investing Cash Flow | -$29K | +95.9% |
| Financing Cash Flow | -$2.6M | -110.0% |
| Free Cash Flow | -$21.1M | +6.0% |